Rohto Pharmaceutical Co.Ltd. (RPHCF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Rohto Pharmaceutical Co.L...

PNK: RPHCF · Real-Time Price · USD
20.09
-6.54 (-24.56%)
At close: Jan 24, 2025, 9:00 PM

Rohto Pharmaceutical Cash Flow Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
41.52B 198.54M 173.57M 151.52M
Depreciation & Amortization
8.69B 58.72M 63.17M 61.07M
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
1.94B 46.16M -3.35M -42.63M
Other Non-Cash Items
-7.08B 19.28M -14.04M -14.6M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-8.88B -43.78M 1.17M -16.92M
Operating Cash Flow
34.24B 232.76M 223.86M 181.07M
Capital Expenditures
-8.91B -74.58M -93.06M -93.25M
Cash Acquisitions
n/a 820.44K -9.78M -8.32M
Purchase of Investments
-9.08B -44.71M -46.13M -19.96M
Sales Maturities Of Investments
1.7B 19.88M 16.13M 36.65M
Other Investing Acitivies
-29M -587.11K -1.93M -7.76M
Investing Cash Flow
-16.32B -99.18M -134.78M -92.64M
Debt Repayment
-1.22B -9.88B 7.59B 834M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-5.47B -4.68B -3.42B -2.96B
Other Financial Acitivies
-7.09B -1.64B -698M -216M
Financial Cash Flow
-13.78B -121.93M 28.51M -21.24M
Net Cash Flow
8.87B 2.3M 109.59M 59.16M
Free Cash Flow
25.33B 158.19M 130.8M 87.82M